Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Search results for: “patient perspective”

  • Optimal Pathologic Staging of Lung Cancer Depends on More Than the Pathologist

    Optimal Pathologic Staging of Lung Cancer Depends on More Than the Pathologist

    By

    Mary Beth Beasley, MD
    Diagnostic Oncology

    Pathology—and pathologic staging in particular—can be improved through multidisciplinary efforts.

  • Early Palliative Care: A European Perspective

    Early Palliative Care: A European Perspective

    By

    Florian Scotté, MD, PhD
    Evolving Standards of Care

    The benefits of early palliative care have been proven. Could negative connotations of palliative care be impeding its adoption?

  • Patient Perspective: The Promise of Personalized Medicine

    Patient Perspective: The Promise of Personalized Medicine

    By

    Angus Pratt, MBA
    Evolving Standards of Care, Patient Advocacy

    Growing treatment options for patients with late-stage lung cancer bring hope—and challenges.

  • The FDA Explained: An Interview with Dr. Harpreet Singh

    The FDA Explained: An Interview with Dr. Harpreet Singh

    By

    Lung Cancer Considered
    Industry News & Regulatory Approvals

    During an episode of IASLC’s Lung Cancer Considered podcast, Dr. Singh provided insight into the US agency’s approval process. Here are some highlights.

  • Patient Perspective: Anxiety Follows Abrupt Departure From Clinical Trial

    Patient Perspective: Anxiety Follows Abrupt Departure From Clinical Trial

    By

    Julie Swedberg, CPA
    Patient Advocacy

    The onboarding required to participate in a clinical trial is extensive. The offboarding, however, can feel like abandonment for some patients.

  • PREMER Results: A Q&A With Dr. Núria Rodriguez de Dios

    PREMER Results: A Q&A With Dr. Núria Rodriguez de Dios

    By

    Joy Curzio
    Radiation Oncology

    Dr. Rodriguez de Dios talks with ILCN about the implications of the PREMER study, a phase III trial comparing PCI with and without hippocampal avoidance in SCLC.

  • GO2 Foundation for Lung Cancer Aims to Create Resources for Caregivers

    GO2 Foundation for Lung Cancer Aims to Create Resources for Caregivers

    By

    Joy Curzio
    Patient Advocacy

    A new survey provides a voice for caregivers regarding the challenges they face and rewards they gain from lung cancer co-survivorship.

  • The Art and Science of Patient–Doctor Communication

    The Art and Science of Patient–Doctor Communication

    By

    Corey J. Langer, MD, FACP, et al.
    Evolving Standards of Care, Patient Advocacy

    When facing a grave illness, especially for the first time, many people are worried, frightened, and overwhelmed. They may have difficulty focusing their attention on daily tasks and experience skewed perceptions and memories based on intense emotions. This distress can also adversely affect the course and severity of disease and the success of its treatment.…

  • Featured Topics

    By

    View News by Topic

  • Increasing Adherence to CT Lung Cancer Screening Programs

    Increasing Adherence to CT Lung Cancer Screening Programs

    By

    Dana Moldovanu, et al.
    Early Detection & Screening

    Two large-scale, randomized controlled trials—the U.S. National Lung Screening Trial (NLST; n = 53,454) and the Dutch–Belgian Randomized Lung Cancer Screening Trial (NELSON; n = 15,792)—have demonstrated that lung cancer screening (LCS) with low-dose CT substantially reduces lung cancer mortality in a high-risk population.1,2 Despite the conclusive evidence for the effectiveness of LCS, national data…

View ILCN Archives

Provider Resources

Popular Articles